SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Opto Circuits soars as its arm starts commercial sale of Freeway 035 long-length DCBs

19 Jan 2021 Evaluate

Opto Circuits (India) is currently trading at Rs. 5.50, up by 0.20 points or 3.77% from its previous closing of Rs. 5.30 on the BSE.

The scrip opened at Rs. 5.47 and has touched a high and low of Rs. 5.55 and Rs. 5.04 respectively. So far 167525 shares were traded on the counter.

The BSE group 'T ' stock of face value Rs. 10 has touched a 52 week high of Rs. 19.85 on 03-Jul-2020 and a 52 week low of Rs. 1.45 on 26-Mar-2020.

Last one week high and low of the scrip stood at Rs. 6.15 and Rs. 5.04 respectively. The current market cap of the company is Rs. 159.33 crore.

The promoters holding in the company stood at 18.52%, while Institutions and Non-Institutions held 0.96% and 80.52% respectively.

Opto Circuits’ (India) subsidiary company -- Eurocor GmbH has started commercial sale of Freeway 035 long-length Drug coated Balloons (DCBs). With the introduction of CE marked 190mm and 230mm catheters, Eurocor Tech GnrbH is one of the only companies world-wide to cater to the specific needs of patients and physicians faced with treatment of challenging long lesions. An ever-growing number of patients worldwide suffer from vascular diseases, most prominently seen in the peripheral area. Moreover, this development also indicates a growing number of patients in critical stages. While DCBs have proven to be an excellent and in most cases the preferred treatment option, it is vitally important to continuously update technologies to optimally treat this high-risk patient group.

Opto Circuits (India) designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.

Opto Circuits (I) Share Price

1.78 0.00 (0.00%)
23-May-2022 18:01 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 547.10
Poly Medicure 1462.20
Laxmi Denta 189.20
Nureca Ltd. 260.95
Hemant Surgical Inds 295.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×